###begin article-title 0
Analysis of Candidate Genes in Occurrence and Growth of Colorectal Adenomas
###end article-title 0
###begin p 1
Recommended by Paul Magnus Schneider
###end p 1
###begin p 2
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
Predisposition to sporadic colorectal tumours is influenced by genes with minor phenotypic effects. A case-control study was set up on 295 patients treated for a large adenoma matched with polyp-free individuals on gender, age, and geographic origin in a 1 : 2 proportion. A second group of 302 patients treated for a small adenoma was also characterized to distinguish effects on adenoma occurrence and growth. We focussed the study on 38 single nucleotide polymorphisms (SNPs) encompassing 14 genes involved in colorectal carcinogenesis. Effect of SNPs was tested using unconditional logistic regression. Comparisons were made for haplotypes within a given gene and for biologically relevant genes combinations using the combination test. The APC p.Glu1317Gly variant appeared to influence the adenoma growth (P = .04, exact test) but not its occurrence. This result needs to be replicated and genome-wide association studies may be necessary to fully identify low-penetrance alleles involved in early stages of colorectal tumorigenesis.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Colorectal cancer (CRC) is one of the most common human malignancies in Western countries. The majority of the cases develop from a premalignant lesion, the adenomatous polyp [1]. Colorectal adenomas have high malignancy potential when they are large in diameter and/or present with severe dysplasia and/or a villous component [2]. Colonoscopic polypectomy has been documented to significantly reduce the incidence of colorectal cancer [3, 4]. Therefore, the identification of factors associated with the development of colorectal adenoma represents a major goal in colorectal cancer prevention. They could indeed allow the selection of individuals at risk of CRC who may benefit from a screening by colonoscopy.
###end p 4
###begin p 5
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
The adenoma-carcinoma sequence suggests that colorectal adenomas and adenocarcinomas share common environmental and genetic risk factors. An increased risk of colorectal tumors has been found in relatives of patients with large adenomas [5, 6]. A case-control study had suggested that family history of colorectal cancer influenced only the growth of adenomas or their malignant transformation [7]. However, relatively few epidemiologic studies explored genetic risk factors in colorectal adenomas.
###end p 5
###begin p 6
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
We investigated, through a case-control study, the relation between polymorphisms within a series of candidate genes involved in colorectal tumorigenesis and putatively in the formation and the development of colorectal adenomas such carcinogen metabolism enzymes, methylation enzymes, DNA repair genes, oncogenes and tumor suppressor genes [8].
###end p 6
###begin title 7
2. Materials and Methods
###end title 7
###begin title 8
###xml 25 33 <span type="species:ncbi:9606">Patients</span>
2.1. Constitution of the Patients and Control Groups
###end title 8
###begin p 9
###xml 122 123 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 365 373 <span type="species:ncbi:9606">Patients</span>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
###xml 953 961 <span type="species:ncbi:9606">patients</span>
###xml 1092 1100 <span type="species:ncbi:9606">Patients</span>
The GEnetics of ADEnomas (GEADE) study is a case-control and family study of patients with high-risk adenomas (>/=10 mm) [9]. The data were obtained from 18 participating gastroenterology units of general hospitals in France. From September 1995 to March 2000, 306 consecutive patients with newly diagnosed colorectal large adenoma (LA) were enrolled in the study. Patients with personal cancer history, familial adenomatous polyposis, established hereditary nonpolyposis colorectal cancer or inflammatory bowel disease were excluded. To distinguish genetic factors involved in the occurrence of adenomas or in their growth, 307 cases with small adenomas (with a diameter smaller than 0.5 cm) (SA) and 572 polyp-free controls (with normal colonoscopy) (PF) were simultaneously enrolled in the same units. All patients and controls were of Caucasian origin. Reason for referral, family history of CRC, completeness of colonoscopy were registered for all patients and controls. Two PF per LA cases were selected as controls within over 2000 PF for matching on age, gender, and geographic area. Patients with SA were relatively rare and could not be matched with LA cases.
###end p 9
###begin p 10
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 710 718 <span type="species:ncbi:9606">patients</span>
Blood specimens were obtained at time of colonoscopy and those patients who presented with a polyp were included only when histological examination revealed the adenomatous nature of the lesion. As polyps were totally removed during colonoscopy, their natural evolution could not be scored. After longitudinally section, half of the tumor material was fixed for histologic analysis and half was frozen for molecular characterization. Twenty individuals had to be excluded because of insufficient tumor material: 11 patients with LA, 5 with SA, and 4 PF. The final groups contained 295 patients with LA, 302 with SA, and 568 PF as controls. Details of these groups have been reported by Lievre et al. [10]. All patients and controls signed an informed consent after approval of the study by an ethic committee for biomedical research (Le Kremlin-Bicetre) and the database was declared to the national committee Commission Nationale de l'Informatique et des Libertes (CNIL).
###end p 10
###begin title 11
2.2. Genes Studied and Genotyping Procedure
###end title 11
###begin p 12
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP1</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3,</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP7</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 354 356 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS</italic>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UGT1A1,</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HRAS1</italic>
###xml 914 932 914 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC, CTNNB1, AXIN2</italic>
###xml 952 961 952 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53, BAX</italic>
###xml 982 988 982 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR2</italic>
###xml 1019 1034 1019 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSH2, MLH1, MYH</italic>
###xml 1041 1047 1041 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
Genes have been selected for their role in colorectal tumorigenesis and for the presence of frequent neutral polymorphisms. The polymorphisms of MMP1, MMP3, and MMP7 gene promoters, that are responsible for the degradation of extracellular matrix components, had been previously studied and were not considered in the present analysis [10]. Three genes, TS, UGT1A1, and MDR1, are implicated in folates, bilirubin metabolism, and transport of xenobiotic respectively. All these pathways are suspected to play a role in cancer occurrence or in the transformation of benign lesions, folates by interfering with DNA synthesis and repair, bilirubin by its known antioxydant properties, and transport of xenobiotic by its detoxication function. Case-control reports [8] exemplified the relevance of these three genes in addition to HRAS1. Three additional pathways have been secondary studied including the WNT pathway (APC, CTNNB1, AXIN2), the p53 pathway (TP53, BAX), the TGFB pathway (TGFBR2), the main MMR and BER genes (MSH2, MLH1, MYH), and CARD15 as part of the family with LRR domains. All these genes have been strongly assessed for their major role in oncogenesis, cycle cell control, apoptosis regulation, cell adhesion and migration, proliferation, DNA repair as their main functions.
###end p 12
###begin p 13
Genotyping has been performed according to the nature of the polymorphisms. Single nucleotide polymorphisms (SNPs) have been characterized by Taqman analysis. The VNTR of HRAS1 was studied by conventional electrophoresis after PCR amplification on 1.2% agarose gels at 2 volts/cm for 15-18 hours.
###end p 13
###begin title 14
2.3. Statistical Analysis
###end title 14
###begin p 15
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1432 1434 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1875 1878 1875 1878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 1883 1886 1883 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH</italic>
###xml 2558 2560 2558 2560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
Hardy-Weinberg proportions were tested for each polymorphism. Linkage disequilibrium (LD) between pairwise loci was estimated using the D' [11] and r2 [12] measures. Association was first tested for each polymorphism separately. Genotype-specific odds ratio (OR) and 95% confidence intervals (CIs) were computed using unconditional logistic regression adjusted on matching factors; Wald test was used to assess the global effect of each polymorphism. The homozygous genotype for the more frequent allele among controls was set as the reference class. Homogeneity of allele frequencies within geographic regions was previously checked. Tests of homogeneity and unconditional logistic regression were done using the SAS package software. The association was further examined using the combination test, that allows the analysis of all possible combinations of SNPs within a given gene or tightly linked genes to test their association with the disease [13]. For each SNPs combination, the method computes a statistic test contrasting the genotypic (or haplotypic) distribution between cases and controls. Because all these tests are correlated (many of them are nested in each other and the SNPs are likely to be in LD), a permutation procedure has been implemented which displays a significance level adequately adjusted for multiple testing. First, we used the FAMHAP12 software to apply this method by performing haplotypic tests [14]. Then the COMBINTEST (Jannot, personal communication) was used to perform genotypic tests. The method was extended to the test of combined polymorphisms on different genes that may act interactively. To avoid multiple tests biases, we chose a three-step strategy that minimizes the number of comparisons. First, we considered two-by-two combinations of polymorphisms chosen on their plausibility to interact with each other, for instance, APC and MYH both responsible, when mutated, for adenomatous polyposis. The second step consisted in considering all combinations within a same pathway. Finally, as a combination of polymorphisms may have an effect even if the genes are not suspected to interact with each other and are not involved in the same pathway, all possible combinations were considered if the first two steps did not reveal any significant association. When several combinations of polymorphisms were significant within a given test, it was possible to test nested combinations using Chi-square calculation to determine whether a given polymorphism adds a significant contribution to the association found [14].
###end p 15
###begin title 16
3. Results
###end title 16
###begin p 17
###xml 36 44 <span type="species:ncbi:9606">patients</span>
The average age was very similar in patients (62 years for LA and 61 years for SA) and in PF controls (61 years). The sex ratio (male/female) was quite similar in LA (1.7) and in PF controls (1.5), slightly lower in SA (1.2) because of the absence of matching.
###end p 17
###begin p 18
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1 </xref>
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53.3</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Table 1 describes the characteristics of the polymorphisms studied and the allele frequencies in controls. The distribution of genotypes in controls was consistent with Hardy-Weinberg proportions for all polymorphisms except for TP53.3 (P = .0013 without correction for multiple testing). A similar departure from H-W proportions (P = .010) was found in the HapMap European population () for this polymorphism.
###end p 18
###begin p 19
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH.1</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH.2</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH.1</italic>
All polymorphisms within a same gene were moderately or not found in LD except MYH; MYH.1 and MYH.2 are in quasicomplete disequilibrium (D' = 1 and R2 = 0.99). As these two polymorphisms appeared to be equivalent, we analysed only MYH.1.
###end p 19
###begin p 20
###xml 170 179 170 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2"> Table 2 </xref>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 291 306 291 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.1, MDR1.2, </italic>
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> AXIN2.9</italic>
###xml 382 389 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
Analysis of single polymorphisms for the different comparisons, LA versus PF, LA versus SA, and SA versus PF did not reveal any association for most of the genes studied. Table 2 indicates the P-values obtained for each polymorphism. The P-values found to be less than .05 were obtained for APC.1, MDR1.2, and AXIN2.9. The corresponding OR and 95% confidence intervals are given in Table 3.
###end p 20
###begin p 21
###xml 119 126 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.1</italic>
###xml 348 359 348 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.1-APC.2</italic>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.2</italic>
###xml 491 494 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 494 495 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 560 565 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.1</italic>
###xml 681 688 679 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC-MYH</italic>
###xml 729 730 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 792 803 790 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC.1-APC.2</italic>
###xml 832 835 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYH</italic>
###xml 908 911 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
The results of the haplotypic and genotypic combination tests performed for each gene or gene combination are shown in Table 4. When considering each gene separately, only APC displayed a significant difference between small and large adenomas (P = .014 in haplotypic analysis and P = .07 in genotypic analysis). As APC.1 alone and the combination APC.1-APC.2 appeared both significant, we tested whether APC.2 provided a significant contribution to the association, which was not the case (chi2 = 2.12, 1df) showing that the association was solely due to the APC.1 (p.Glu1317Gln) polymorphism. Logistic regression indicated an odds ratio of 7.95 (CI: 1.05-354.3). The combination APC-MYH appeared also significant with a global P-value of .045. However, the only significant combination was APC.1-APC.2 already found, showing that MYH does not provide any additional contribution to the association between APC and adenomas. No difference was found for the other two comparisons, that is, SA versus PF and LA versus PF. Finally, the analysis of all possible combinations did not provide any significant result.
###end p 21
###begin title 22
4. Discussion
###end title 22
###begin p 23
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 541 544 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP</italic>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 736 745 736 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP1-MMP3</italic>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
We investigated the role of candidate gene polymorphisms in a case-control study of patients with large adenomatous polyps (n = 295), compared to patients with small adenomatous polyps (n = 302) and polyp-free controls (n = 568). The 38 polymorphisms studied belonged to 14 genes possibly involved in increasing of colorectal cancer risk [8]. The reason for comparing these different groups of patients was that different genes might be involved in the different steps of carcinogenesis [7]. Using this case-control study, we had shown that MMP polymorphism was most probably involved in the occurrence, but not in the growth of polyps [10]. Using the combination test, we had shown that the effect was due to a specific combination of MMP1-MMP3 polymorphisms which was not found using logistic regression. Indeed, a major property of this test is that it allows the detection of polymorphisms with low marginal effects [13].
###end p 23
###begin p 24
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AXIN2</italic>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
Multiple testing may be a limitation of studies in which several polymorphisms in several genes are tested. The combination test allows a correction for multiple tests on tightly linked markers, which other methods of correction such as Bonferroni, Benjamini-Hochberg, or FDR (false discovery rate) do not. In the present study, we could show that the positive results obtained for AXIN2 and MDR1 when analyzing single polymorphisms were false positives as these results were not confirmed when using the combination test. For independent markers, there was no need for correcting for multiple testing as our results were essentially negative.
###end p 24
###begin p 25
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Our study did not give evidence for an effect of any of the gene polymorphisms studied except the p.Glu1317Gly variant of the APC gene. This variant was already described in the previous studies with apparently conflicting results. Some studies reported an effect of this variant in patients with multiple adenomas or colorectal cancer [15-17], and some others found an effect in adenomas but not in cancer [18, 19]. More recently, Hahnloser et al. [20] reported an effect of this variant in a group of patients with a small number of adenomas (1 to 3 lifetime adenomas) and in a group of CRC cases. None of these studies considered the size of adenomas and could differentiate adenomas at high-risk from those at low-risk of cancer. Our results favour the hypothesis that the p.Glu1317Gly variant would influence the growth and not the occurrence of adenomas, and would have thus indirectly an influence on colorectal cancer risk. Nevertheless, although the three groups are paired on gender and geographic origin, it is not stated if other known risk factors would influence adenoma growth. It is thus important to plan a specific multivariate analysis when building a replication sample.
###end p 25
###begin p 26
###xml 14 16 14 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS</italic>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS</italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS.2</italic>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS.2</italic>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1031 1033 1031 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS</italic>
###xml 1551 1553 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1441 1449 <span type="species:ncbi:9606">patients</span>
Regarding the TS polymorphisms, we did not confirm the effect of TS suggested in some studies. Chen et al. [21] found a significant effect of the 3R allele of TS.2, particularly of the 3R/3R genotype (OR = 3.3). In our study, the OR associated with 3R/3R genotype was 1.43 (CI 0.94-2.16) for LA versus PF and 1.10 (CI 0.68-1.78) for LA versus SA. On the other hand, Ulrich et al. [22] found no marginal effect with any of these two polymorphisms but found a significant interaction of TS.2 with folate intake. Similarly, the most recent studies [23, 24] found no marginal effect of either polymorphism but a slight interaction with folate or vitamin B6 intake. The groups' sizes in our study were of the same order of magnitude as in the study of Chen et al. [21], but the three other studies which did not show any marginal effect included larger groups (more than 500 individuals in each group). Given the size of our population, we could a priori detect an OR of 1.7 with a power of at least 80%. It is highly probable that the TS gene, which produces a key enzyme in folate metabolism, has an effect only in interaction with dietary exposures, which would explain why this effect was not found in our study. Moreover a new SNP has been recently identified in the second repeat of the 3R allele leading to split the allele 3R in 3RC and 3RG alleles as a tri-allelic polymorphism. This variant could explain these discrepant results since patients with 3RC/3RC genotype have a transcriptional activity of TS comparable to those with 2R/2R genotype [25].
###end p 26
###begin p 27
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
In our study, the problem of multiple testing was adequately controlled for each test performed by the permutation procedure implemented in the combination test. In the last analysis step, the tremendous number of comparisons resulted in a drastic correction of each P-value, which considerably lowered the testing power. Thus, our negative results certainly do not definitively demonstrate the absence of specific combination influencing colorectal tumorigenesis, but more probably that, if it exists, this (of these) effect(s) is (are) low and could be found through the initial (and further) genome-wide association studies of colorectal cancer testing much larger numbers of patients and controls [26, 27].
###end p 27
###begin title 28
Acknowledgments
###end title 28
###begin p 29
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 706 710 <span type="species:ncbi:9606">Mans</span>
###xml 724 728 <span type="species:ncbi:9606">Mans</span>
This work was supported by grants from the French National Society of Gastroenterology, the Ligue Nationale contre le Cancer (France), the Association pour la Recherche sur le Cancer, the Regional Council of Burgundy, the Fondation de France and the French Ministry of Health (PHRC). The authors are indebted to Chantal Milan, Nicole Pajot, and Catherine Paoletti for their help in the data management. They also are grateful to the ANGH group who was responsible for patients recruitment: P Berthelemy (Pau), P Cassan (Vichy), M Glikmanas (Meaux), G Gatineau-Sailliant (Meaux), A Courrier (Metz), D Pillon (Bourg-en-Bresse), JP Michalet (Beaune), JP Latrive (Compiegne), J Guillan (Evreux), A Blanchi (Le Mans), B Bour (Le Mans), T Morin (Tarbes), JL Legoux (Orleans), D Labarriere (Orleans), B Naudy (Toulon), D Goldfain (Dreux), C Bories (Beauvais), J Andrieu (Le Chesnay), and JL Staub (Niort).
###end p 29
###begin article-title 30
A genetic model for colorectal tumorigenesis
###end article-title 30
###begin article-title 31
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
###end article-title 31
###begin article-title 32
Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer
###end article-title 32
###begin article-title 33
Prevention of colorectal cancer by colonoscopic polypectomy
###end article-title 33
###begin article-title 34
A systematic review and meta-analysis of familial colorectal cancer risk
###end article-title 34
###begin article-title 35
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors
###end article-title 35
###begin article-title 36
Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study
###end article-title 36
###begin article-title 37
Polymorphisms and colorectal tumor risk
###end article-title 37
###begin article-title 38
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas
###end article-title 38
###begin article-title 39
Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma
###end article-title 39
###begin article-title 40
The Interaction of selection and linkage. I. General considerations: heterotic models
###end article-title 40
###begin article-title 41
Linkage disequilibrium in finite populations
###end article-title 41
###begin article-title 42
Improved use of SNP information to detect the role of genes
###end article-title 42
###begin article-title 43
A powerful strategy to account for multiple testing in the context of haplotype analysis
###end article-title 43
###begin article-title 44
Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis
###end article-title 44
###begin article-title 45
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history
###end article-title 45
###begin article-title 46
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q
###end article-title 46
###begin article-title 47
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Prevalence of the APC E1317Q variant in colorectal cancer patients
###end article-title 47
###begin article-title 48
###xml 85 93 <span type="species:ncbi:9606">patients</span>
APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients
###end article-title 48
###begin article-title 49
The APC E1317Q variant in adenomatous polyps and colorectal cancers
###end article-title 49
###begin article-title 50
Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas
###end article-title 50
###begin article-title 51
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thymidylate synthase</italic>
Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas
###end article-title 51
###begin article-title 52
Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
###end article-title 52
###begin article-title 53
Dietary intake of B-vitamins, polymorphisms in thymidylate synthase and serine hydroxymethyltransferase 1, and colorectal adenoma risk: a dutch case-control study
###end article-title 53
###begin article-title 54
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
###end article-title 54
###begin article-title 55
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
###end article-title 55
###begin article-title 56
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21
###end article-title 56
###begin p 57
 Characteristics of the polymorphisms and minor allele frequencies (MAF) in polyp-free controls.
###end p 57
###begin p 58
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
 Association analysis between single polymorphisms and colorectal adenomas: P-values.
###end p 58
###begin p 59
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P-value for the Wald test assessing the global effect of SNP, uncorrected for multiple testing.
###end p 59
###begin p 60
 **LA large adenoma, SA small adenoma, PF polyp-free.
###end p 60
###begin p 61
 ***Exact test.
###end p 61
###begin p 62
 Association analysis between single polymorphisms and colorectal adenomas.
###end p 62
###begin p 63
*The genotype not shown is the reference one.
###end p 63
###begin p 64
 **OR adjusted on age, sex, and group of centres; 95% CI is given into brackets.
###end p 64
###begin p 65
 ***Very few individuals with the homozygous genotype were observed.
###end p 65
###begin p 66
Effect of combinations of gene polymorphisms in colorectal adenomas.
###end p 66
###begin p 67
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
 (a) P-values of combinations of polymorphisms withthin single genes.
###end p 67
###begin p 68
###xml 5 6 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
 (b) P-values of combinations of polymorphisms in different genes.
###end p 68

